(NASDAQ: SANA) Sana Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 1,251.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 29.08%.
Sana Biotechnology's revenue in 2023 is $0.On average, 1 Wall Street analysts forecast SANA's revenue for 2027 to be $3,646,964,348, with the lowest SANA revenue forecast at $3,646,964,348, and the highest SANA revenue forecast at $3,646,964,348. On average, 1 Wall Street analysts forecast SANA's revenue for 2028 to be $13,050,218,370, with the lowest SANA revenue forecast at $13,050,218,370, and the highest SANA revenue forecast at $13,050,218,370.
In 2029, SANA is forecast to generate $31,166,760,185 in revenue, with the lowest revenue forecast at $31,166,760,185 and the highest revenue forecast at $31,166,760,185.